Rationale: Although the mortality of severe coronavirus disease 2019 (COVID-19) has decreased after the emergence of the Omicron variant, it remains high in patients on hemodialysis (HD). Remdesivir (RDV) is considered as the first line drug for hospitalized COVID-19 patients, however the evidence regarding the usage in HD patients is lacking because clinical trials of RDV have excluded HD patients for safety reasons. Thus, accumulation of knowledge on the regimen, efficacy, and tolerability of RDV in HD patients is important.
View Article and Find Full Text PDFGreen nail syndrome is an infectious nail disorder caused most commonly by . We report a rare case of peritoneal dialysis (PD) exit site infection (ESI) accompanied by -associated green nail syndrome. The patient was treated with oral and topical antibiotics without the need for PD catheter removal.
View Article and Find Full Text PDF